Avid Bioservices to Participate at Upcoming Investor Conferences
May 07, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
May 07, 2024 10:00 ET
|
Dipharma Francis S.r.l
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising Focus on Personalized Medicine and Niche Therapies Worldwide
May 02, 2024 06:19 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule CMO/CDMO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global small molecule CMO/CDMO market...
Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage
April 25, 2024 11:16 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Inhalation CDMO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The inhalation CDMO market size has grown...
Integer Holdings Corporation Reports First Quarter 2024 Results
April 25, 2024 08:00 ET
|
Integer Holdings Corporation
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today...
Mithra secures court protection measures to advance monetization process
April 22, 2024 01:00 ET
|
Mithra Pharmaceuticals
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
April 08, 2024 16:05 ET
|
Societal CDMO, Inc.; CoreRx, Inc.
CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract...
Global Pharmaceutical CDMO Market Analysis Report 2024-2030: AI-Assisted Drug Active Pharmaceutical Ingredient (API) Synthesis Gaining Attention
April 08, 2024 10:26 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial),...
Investigation into Avid Bioservices, Inc. Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know!
April 03, 2024 04:45 ET
|
Johnson Fistel, LLP
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Avid Bioservices, Inc.
Global Pharmaceutical CDMO Market to Soar with Projected Growth of 6.74% CAGR from 2024 to 2029
April 01, 2024 17:21 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts...